Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Cephalexin for Cellulitis Pilot
NCT04471246Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Aug 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefalexin in cellulitis, sponsored by Ottawa Hospital Research Institute. Started Aug 2021; status: completed.
02
Drugs
cefalexin
03
Conditions
cellulitis
Beyond the preview
Go deeper on NCT04471246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04471246.